PGF and coronary artery disorder: This study aimed to evaluate biomarkers of placental angiogenesis, soluble fms-like tyrosine kinase-1 (sFlt-1) and placental growth factor (PlGF), in pregnant women with CHD and assess their association with adverse pregnancy outcomes.